Organization

University of Pittsburgh

12 clinical trials

16 abstracts

1 poster

Poster

Mepolizumab Improves Health-Related Quality of Life for Patients With Chronic Rhinosinusitis With Nasal Polyps: Data From the SYNAPSE Study

Abstract

Belzutifan treatment for von Hippel-Lindau (VHL) disease–associated central nervous system (CNS) hemangioblastomas (HBs) in the phase 2 LITESPARK-004 study.

Org: Massachusetts General Hospital Cancer Center and Harvard Medical School, Vanderbilt University Medical Center, University of Utah, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Merck & Co., Inc.,

Abstract

Correlation of serum anti-Müllerian hormone (AMH) levels on identification of premenopausal patients (pts) with hormone receptor positive (HR+), HER2-negative, node-positive breast cancer most likely to benefit from adjuvant chemotherapy in SWOG S1007 (RxPONDER).

Org: Winship Cancer Institute, Emory University, Atlanta, GA, USA, Cancer Research and Biostatistics, University of Kansas Medical Center, ASCO,

Abstract

Org: University of Kansas Medical Center, Mayo Clinic, Mayo Clinic Cancer Center, Washington University in St. Louis, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute,

Abstract

SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.

Org: UPMC Hillman Cancer Center, Mayo Clinic Rochester, Melanoma Institute Australia, University of Sydney and Sydney Cancer Centre, Chris O'Brien Lifehouse,

Abstract

Efficacy and genomic analysis of HER2-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial.

Org: Memorial Sloan Kettering Cancer Center, University of Washington School of Medicine and Fred Hutchinson Cancer Center, University of Pittsburgh, Washington University School of Medicine, Kaplan Hospital,

Abstract

Transcriptomic analysis of cAMP/PKA/CREB signaling in invasive lobular breast cancer.

Org: Washington University School of Medicine, University of Pittsburgh,

Abstract

Overall survival with palbociclib (PAL) plus an aromatase inhibitor (AI) versus AI alone in older patients (pts) with de novo, HR+/HER2− metastatic breast cancer: A SEER-Medicare analysis.

Org: Pfizer AB, Pfizer Inc., RTI Health Solutions, University of Pittsburgh, University of California Irvine,

Abstract

Disparities in stage at presentation for disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) groups with breast cancer.

Org: University of Pennsylvania, Harvard University, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, University of Rochester, University of Pittsburgh,

Abstract

Correlation of TILs indices generated by visual review and digital computational algorithm with outcomes from preoperative chemotherapy for TNBC in TBCRC 030.

Org: Dana-Farber Cancer Institute, 4D Path Inc., Vanderbilt University Medical Center, University of Pittsburgh, O'Neal Comprehensive Cancer Center at UAB,

Abstract

Study of the Bria-IMT regimen and CPI vs physicians' choice in advanced metastatic breast cancer (BRIA-ABC).

Org: University of Washington School of Medicine and Fred Hutchinson Cancer Center, Mayo Clinic Florida, University of Pittsburgh, Hoag Cancer Center, Newport Beach, CA, Morehouse School of Medicine,

Abstract

Trends in location of death for individuals with pediatric cancer in the United States.

Org: University of Pittsburgh, Yale College, Stanford School of Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, NYC Health + Hospitals/Elmhurst,

Abstract

Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas.

Org: University of Pittsburgh, University of Pittsburgh Cancer Institute, UPMC Cancer Center - Hillman Cancer Center,

Abstract

A phase II trial of nivolumab plus axitinib in patients with anti-PD1 refractory advanced melanoma.

Org: UPMC Hillman Cancer Center, Pittsburgh, PA, UT Health Science Center at San Antonio, Mays Cancer Center, San Antonio, TX,

Abstract

Generative AI enhanced with NCCN clinical practice guidelines for clinical decision support: A case study on bone cancer.

Org: UPMC Hillman Cancer Center, University of Pittsburgh,

Abstract

Randomized phase II trial of pembrolizumab/lenvatinib (P+L) +/- responder fecal microbiota transplant (R-FMT) in PD-1 relapsed/refractory (R/R) cutaneous melanoma (MEL).

Org: UPMC Hillman Cancer Center, University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), Nihon Medi-Physics,